ArticleHemaSphere2020

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials.

Jorge J Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.